Drug composition
    1.
    发明授权
    Drug composition 有权
    药物组成

    公开(公告)号:US06277888B1

    公开(公告)日:2001-08-21

    申请号:US09380274

    申请日:2000-01-06

    IPC分类号: A61K31135

    摘要: The present invention provides a pharmaceutical composition containing 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol or a pharmaceutically acceptable acid addition salt thereof and a lecithin, and containing a saccharide if desired, which can be formulated into a liquid preparation, and which is suitable for the suppression of rejection in organ or bone marrow transplantation, for an immunosuppressive sustention therapy or for the treatment of autoimmune diseases.

    摘要翻译: 本发明提供含有2-氨基-2- [2-(4-辛基苯基)乙基]丙烷-1,3-二醇或其药学上可接受的酸加成盐和卵磷脂的药物组合物,如果需要,含有糖类, 其可以配制成液体制剂,并且其适用于抑制器官或骨髓移植中的排斥反应,免疫抑制维持治疗或用于治疗自身免疫性疾病。